Curie Capital

Overview

Curie Capital is a life sciences-focused venture capital firm based in Amsterdam, Netherlands. Founded in 2018, the firm specializes in early-stage investments in biotechnology, pharmaceutical, and medical technology companies. Curie Capital seeks to empower innovative start-ups by providing not only capital but also strategic support to build successful companies. The firm's investment strategy focuses on Seed and Series A stage companies, particularly those developing therapeutics, diagnostics, or class IIb and III medical devices. Curie Capital typically invests in companies headquartered in the Netherlands that have not raised more than €3.5 million in equity or convertible loan agreements. The firm collaborates with experienced co-investors and offers portfolio companies access to a broad network and expertise across various areas. Curie Capital's team comprises life science experts and business analysts who guide companies throughout the research and development process. The founding partners, Mariette van der Velden and Han de Groot, bring extensive experience in investing, entrepreneurship, and managing companies from startup to public exit. Their complementary skills and networks contribute to the success of their portfolio companies.

Investment Focus

• Companies headquartered in the Netherlands
• Not raised more than €3.5 million in equity or convertible loan agreements

Portfolio Companies